Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Development and bioavailability assessment of ramipril nanoemulsion formulation.

Development and bioavailability assessment of ramipril nanoemulsion formulation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Development and bioavailability assessment of ramipril nanoemulsion formulation. Abstract Text:

    sheikh shafiqSheikh Shafiq,faiyaz shakeelFaiyaz Shakeel,sushma talegaonkarSushma Talegaonkar,farhan j ahmadFarhan J Ahmad,roop k kharRoop K Khar,mushir aliMushir Ali,sheikh shafiqSheikh Shafiq,faiyaz shakeelFaiyaz Shakeel,sushma talegaonkarSushma Talegaonkar,farhan j ahmadFarhan J Ahmad,roop k kharRoop K Khar,mushir aliMushir Ali,

    The objective of our investigation was to design a thermodynamically stable and dilutable nanoemulsion formulation of Ramipril, with minimum surfactant concentration that could improve its solubility, stability and oral bioavailability. Formulations were taken from the o/w nanoemulsion region of phase diagrams, which were subjected to thermodynamic stability and dispersibility tests. The composition of optimized formulation was Sefsol 218 (20% w/w), Tween 80 (18% w/w), Carbitol (18% w/w) and standard buffer solution pH 5 (44% w/w) as oil, surfactant, cosurfactant and aqueous phase, respectively, containing 5 mg of ramipril showing drug release (95%), droplet size (80.9 nm), polydispersity (0.271), viscosity (10.68 cP), and infinite dilution capability. In vitro drug release of the nanoemulsion formulations was highly significant (p<0.01) as compared to marketed capsule formulation and drug suspension. The relative bioavailability of ramipril nanoemulsion to that of conventional capsule form was found to be 229.62% whereas to that of drug suspension was 539.49%. The present study revealed that ramipril nanoemulsion could be used as a liquid formulation for pediatric and geriatric patients and can be formulated as self-nanoemulsifying drug delivery system (SNEDDS) as a unit dosage form.

    Development and bioavailability assessment of ramipril nanoemulsion formulation. Publishing Authors By Initials

    s shafiqS Shafiq,f shakeelF Shakeel,s talegaonkarS Talegaonkar,fj ahmadFJ Ahmad,rk kharRK Khar,m aliM Ali,s shafiqS Shafiq,f shakeelF Shakeel,s talegaonkarS Talegaonkar,fj ahmadFJ Ahmad,rk kharRK Khar,m aliM Ali,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Development and bioavailability assessment of ramipril nanoemulsion formulation. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: European journal of pharmaceutics and biopharmaceu

    VOLUME: 66

    Page Numbers: 227-43

    Journal Abbreviation:

    ISSN: 0939-6411

    DAY: 24

    MONTH: 10

    YEAR: 2006

    Development and bioavailability assessment of ramipril nanoemulsion formulation. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9109778

    Development and bioavailability assessment of ramipril nanoemulsion formulation. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Development and bioavailability assessment of ramipril nanoemulsion formulation. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Development and bioavailability assessment of ramipril nanoemulsion formulation.

    AFFILIATION: Department of Pharmaceutics, Jamia Hamdard, Hamdard Nagar, India. shafiq_sheikh@fastmail.fm

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Eur J Pharm Biopharm

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Development and bioavailability assessment of ramipril nanoemulsion formulation Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News